[go: up one dir, main page]

WO2003047596A2 - Ointment for soothing dermatitis - Google Patents

Ointment for soothing dermatitis Download PDF

Info

Publication number
WO2003047596A2
WO2003047596A2 PCT/FR2002/004085 FR0204085W WO03047596A2 WO 2003047596 A2 WO2003047596 A2 WO 2003047596A2 FR 0204085 W FR0204085 W FR 0204085W WO 03047596 A2 WO03047596 A2 WO 03047596A2
Authority
WO
WIPO (PCT)
Prior art keywords
ointment
skin
dermatitis
constituents
duck
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2002/004085
Other languages
French (fr)
Other versions
WO2003047596A3 (en
Inventor
Margaret Bronnert
Nicole Bauchet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AU2002365642A priority Critical patent/AU2002365642A1/en
Publication of WO2003047596A2 publication Critical patent/WO2003047596A2/en
Publication of WO2003047596A3 publication Critical patent/WO2003047596A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Definitions

  • the present invention relates to an ointment intended to be applied to the skin of people suffering from dermatitis, dry skin, hyperkeratinosis, atopic eczema and psoriasis.
  • the existing ointments and creams have a medicinal approach to dermatitis and are mainly composed of elements of plant and / or mineral origin and sometimes contain elements not devoid of side effects. Dermatitis, sources of itching and intense irritation are often recurrent and resistant to treatment.
  • the proposed ointment is formulated from lipids 100% of animal origin; firstly neutral lipids (triglycerides) from duck fat and secondly polyunsaturated fatty acids, omega 3 and vitamins A, D, and E from fish liver oil.
  • the purified cod liver oil used has the following analysis: for
  • the ointment does not contain elements known for their side effects which is important in the case of prolonged treatments or on sensitive areas, around the eyes, the mouth, especially in children.
  • the odors of the components neutralize each other for the most part without special treatment.
  • a perfume may be considered in the form of an essential oil which is not irritating to the skin.
  • the ointment is made from:
  • Fats from species other than duck whose particularity is resistance to cold, can be used. Liver oil from other fish species can be used if analyzes show a similarity in their components. The proportions are not limiting but seem to be optimal.
  • the ointment can be stored for several weeks in the refrigerator. Larger scale production would involve a sterilization stage with the usual precautions to preserve the vitamins. This would allow long storage at room temperature before opening the jar.
  • This ointment is intended for the relief of itching and irritation of the skin during dermatitis, atopic eczema and psoriasis, dry skin and hyperkeratinosis and for the progressive improvement of the condition of the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns a greasy ointment of animal origin for relieving skin itching and irritation caused by dermatitis, atopic eczema and psoriasis, skin dryness and hyperkeratinosis. Existing ointments and creams consist mainly of plant and/or mineral constituents. Said ointment is different from others by its animal constituents: 90 to 95 % of lipids (triglycerides) derived from duck internal subcutaneous fat and 5 to 10 % of polyunsaturated fatty acids (omega 3) and vitamins A, D and E derived from cod liver oil. It does not contain any constituents known for their secondary effects. Its easy absorption by the skin enables fast relief of the symptoms of said diseases while gradually enhancing skin condition.

Description

Pommade pour soulager les dermites Ointment to relieve dermatitis

La présente invention concerne une pommade destinée à être appliquée sur la peau de personnes souffrant de dermites, sécheresse cutanée, hyperkératinose, eczéma atopique et psoriasis.The present invention relates to an ointment intended to be applied to the skin of people suffering from dermatitis, dry skin, hyperkeratinosis, atopic eczema and psoriasis.

Les pommades et crèmes existantes ont une approche médicamenteuse aux dermites et sont composées en majeur partie d'éléments d'origine végétale et / ou minérale et contiennent parfois des éléments non dépourvus d'effets secondaires. Les dermites, sources de démangeaisons et irritations intenses sont souvent récurrentes et résistantes aux traitements.The existing ointments and creams have a medicinal approach to dermatitis and are mainly composed of elements of plant and / or mineral origin and sometimes contain elements not devoid of side effects. Dermatitis, sources of itching and intense irritation are often recurrent and resistant to treatment.

La pommade proposée est formulée à partir de lipides 100% d'origine animale ; d'une part des lipides neutres (triglycérides) provenant des graisses de canard et d'autre part des acides gras polyinsaturés, oméga 3 et les vitamines A, D, et E provenant de l'huile de foie de poisson. L'huile de foie de morue purifiée utilisée présente l'analyse suivante : pourThe proposed ointment is formulated from lipids 100% of animal origin; firstly neutral lipids (triglycerides) from duck fat and secondly polyunsaturated fatty acids, omega 3 and vitamins A, D, and E from fish liver oil. The purified cod liver oil used has the following analysis: for

10ml :10ml:

Oméga 3 - EPA 828 mg - DHA 736 mgOmega 3 - EPA 828 mg - DHA 736 mg

Vitamines A 4000 LUVitamins A 4000 LU

D 400 LU E 10 LU.D 400 LU E 10 LU.

Ceci donne une pommade grasse présentant une affinité avec la peau qui l'absorbe très vite ce qui facilite l'application même sur des surfaces étendues. Les démangeaisons et irritations sont rapidement atténuées. L'état de la peau se trouve progressivement amélioré. Après l'application, il reste une pellicule protectrice qui prévient le dessèchement.This gives a greasy ointment with an affinity for the skin which absorbs it very quickly which facilitates application even on large surfaces. The itching and irritation is quickly reduced. The condition of the skin is gradually improved. After application, a protective film remains which prevents drying out.

II est possible que l'effet d'apaisement provienne d'un élément présent dans la graisse de canard et encore non identifié.It is possible that the calming effect comes from an element present in duck fat and still not identified.

La pommade ne contient pas d'éléments connus pour leurs effets secondaires ce qui est important dans les cas de traitements prolongés ou sur les zones sensibles, autour des yeux, la bouche, notamment chez les enfants. Les odeurs des composants se neutralisent l'une l'autre en grande partie sans traitement particulier. Toutefois un parfum peut-être envisagé sous forme d'une huile essentielle non irritante pour la peau.The ointment does not contain elements known for their side effects which is important in the case of prolonged treatments or on sensitive areas, around the eyes, the mouth, especially in children. The odors of the components neutralize each other for the most part without special treatment. However, a perfume may be considered in the form of an essential oil which is not irritating to the skin.

La pommade est réalisée à partir de :The ointment is made from:

- 90 à 95% de graisse de canard sous cutanée et interne fondue à basse température (50° c maximum), suffisante pour faire fondre la graisse sans la brûler. L'huile obtenue est filtrée. - 5 à 10% d'huile de foie de morue incorporée et bien mélangée à l'huile de canard refroidie mais pas figée.- 90 to 95% of subcutaneous and internal duck fat melted at low temperature (50 ° C maximum), sufficient to melt the fat without burning it. The oil obtained is filtered. - 5 to 10% of cod liver oil incorporated and well mixed with the duck oil cooled but not frozen.

Il est possible d'améliorer l'aspect cosmétique de la pommade en incorporant à froid de l'eau distillée.It is possible to improve the cosmetic aspect of the ointment by incorporating distilled water when cold.

Les graisses d'autres espèces que le canard, dont la particularité est la résistance au froid, peuvent être utilisées. L'huile de foie d'autres espèces de poisson peut être utilisée si les analyses démontrent une similitude dans leurs composants. Les proportions ne sont pas limitatives mais semblent être optimales.Fats from species other than duck, whose particularity is resistance to cold, can be used. Liver oil from other fish species can be used if analyzes show a similarity in their components. The proportions are not limiting but seem to be optimal.

Fabriquée de façon artisanale, sans conservateur, la pommade se conserve plusieurs semaines au réfrigérateur. Une production à plus grande échelle comporterait un stade de stérilisation avec les précautions usuelles pour préserver les vitamines. Ceci permettrait une longue conservation à température ambiante avant ouverture du pot.Hand-made, without preservatives, the ointment can be stored for several weeks in the refrigerator. Larger scale production would involve a sterilization stage with the usual precautions to preserve the vitamins. This would allow long storage at room temperature before opening the jar.

Cette pommade est destinée au soulagement des démangeaisons et irritations de la peau lors de dermites, eczéma atopique et psoriasis, sécheresse cutanée et hyperkératinose et à l'amélioration progressive de l'état de la peau. This ointment is intended for the relief of itching and irritation of the skin during dermatitis, atopic eczema and psoriasis, dry skin and hyperkeratinosis and for the progressive improvement of the condition of the skin.

Claims

REVENDICATIONS 1) Pommade grasse caractérisée par son contenu en lipides : 100% animale, élaborée à partir de graisse (sous-cutanée et interne) de certaines espèces d'oiseaux génétiquement résistants au froid (anatidés) et d'huile de foie de poisson ; pommade destinée à soulager les démangeaisons et irritations de la peau dues aux dermites, eczéma atopique et psoriasis, sécheresse cutanée et hyperkératinose.1) Oily ointment characterized by its lipid content: 100% animal, made from fat (subcutaneous and internal) from certain species of birds genetically resistant to cold (anatidae) and fish liver oil; ointment intended to relieve itching and irritation of the skin due to dermatitis, atopic eczema and psoriasis, dry skin and hyperkeratinosis. 2) Pommade selon la revendication 1 caractérisée en ce que les lipides d'origine animale proviennent du canard.2) Ointment according to claim 1 characterized in that the lipids of animal origin come from duck. 3) Pommade selon les revendications 1 et 2 caractérisée en ce que les lipides d'origine animale sont élaborés en faisant fondre les graisses de canard à basse température (50° c maximum).3) Ointment according to claims 1 and 2 characterized in that the lipids of animal origin are produced by melting the duck fat at low temperature (50 ° c maximum). 4) Pommade selon la revendication 3 caractérisée en ce que le constituant huile de foie de poisson est incorporé après filtration et refroidissement de la graisse de canard. 4) Ointment according to claim 3 characterized in that the fish liver oil component is incorporated after filtration and cooling of the duck fat.
PCT/FR2002/004085 2001-12-06 2002-11-28 Ointment for soothing dermatitis Ceased WO2003047596A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365642A AU2002365642A1 (en) 2001-12-06 2002-11-28 Ointment for soothing dermatitis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/15754 2001-12-06
FR0115754A FR2833174B1 (en) 2001-12-06 2001-12-06 FAT OINTMENT OF ANIMAL ORIGIN INTENDED TO RELIEVE SKIN IRRITATIONS AND IRRITATIONS DUE TO DERMITES, ATOPIC ECZEMA AND PSORIASIS, SKIN DROUGHT AND HYPERKERATINOSIS

Publications (2)

Publication Number Publication Date
WO2003047596A2 true WO2003047596A2 (en) 2003-06-12
WO2003047596A3 WO2003047596A3 (en) 2004-01-22

Family

ID=8870159

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/004085 Ceased WO2003047596A2 (en) 2001-12-06 2002-11-28 Ointment for soothing dermatitis

Country Status (3)

Country Link
AU (1) AU2002365642A1 (en)
FR (1) FR2833174B1 (en)
WO (1) WO2003047596A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013542222A (en) * 2010-10-27 2013-11-21 ネステク ソシエテ アノニム Methods and compositions suitable for promoting healthy skin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
DE4435290A1 (en) * 1994-10-01 1996-04-04 Beiersdorf Ag Dermatological preparations containing fatty acids and fatty acid glycerides against superinfections
WO1996028150A1 (en) * 1995-02-20 1996-09-19 Marit Eriksen Therapeutic skin cream

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013542222A (en) * 2010-10-27 2013-11-21 ネステク ソシエテ アノニム Methods and compositions suitable for promoting healthy skin
EP2632414A4 (en) * 2010-10-27 2014-03-12 Nestec Sa METHODS AND COMPOSITIONS HAVING THE EFFECT OF PROMOTING SKIN HEALTH
US9301973B2 (en) 2010-10-27 2016-04-05 Nestec S.A. Methods and compositions suitable for promoting healthy skin
AU2011320994B2 (en) * 2010-10-27 2016-08-25 Nestec S.A. Methods and compositions suitable for promoting healthy skin

Also Published As

Publication number Publication date
WO2003047596A3 (en) 2004-01-22
AU2002365642A1 (en) 2003-06-17
AU2002365642A8 (en) 2003-06-17
FR2833174B1 (en) 2004-05-28
FR2833174A1 (en) 2003-06-13

Similar Documents

Publication Publication Date Title
KR0129666B1 (en) Essenial fatty acid composition
Lluís et al. Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1: 1 ratio on cardiovascular disease risk markers in rats
Khoshnam et al. Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion
ES2364443T3 (en) THE SOLID OIL POWDER.
Khan et al. Sunflower oil: Efficient oil source for human consumption
Soldo et al. High quality oil extracted from sardine by‐products as an alternative to whole sardines: Production and refining
Kim et al. Anti-inflammatory action of dietary fish oil and calorie restriction
Mohagheghi et al. Dietary virgin olive oil reduces blood brain barrier permeability, brain edema, and brain injury in rats subjected to ischemia‐reperfusion
Womeni The chemical composition, fatty acid, amino acid profiles and mineral content of six fish species commercialized on the Wouri river coast in Cameroon
Singh Dietary sources of omega-3 fatty acids versus omega-3 fatty acid supplementation effects on cognition and inflammation
Carrillo et al. N-3 fatty acid content in eggs laid by hens fed with marine algae and sardine oil and stored at different times and temperatures
Richard et al. Micronutrients and ageing: intakes and requirements
FR2762993A1 (en) NEW USE OF PHOSPHOLIPIDS OF ANIMAL ORIGIN IN THERAPEUTICS AND / OR DIETETICS
JP2009298810A (en) Composition comprising thylakoid useful in modulation of inflammation process
WO2003047596A2 (en) Ointment for soothing dermatitis
Pagan et al. Long-chain polyunsaturated fatty acid supplementation increases levels in red blood cells and reduces the prevalence and severity of squamous gastric ulcers in exercised Thoroughbreds
de Arruda et al. A single administration of fish oil inhibits the acute inflammatory response in rats
FR3130555A3 (en) Composition comprising at least one boswellic acid and/or at least one plant extract comprising at least one boswellic acid for topical use in the treatment of inflammatory skin diseases
Barcelos et al. Effects of ω-3 essential fatty acids (ω-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter
Percival Understanding the natural management of pain and inflammation
Stice Omega fatty acids
FR2788666A1 (en) FEED FOR BREEDING ANIMALS FOR THE PRODUCTION OF FATTY ACID [n-3] POLYUNSATURATED MEAT AND FEEDING METHOD THEREOF
AU2012277977A1 (en) DHA and EPA in the reduction of oxidative stress
MA27669A1 (en) STABILIZED TOPICAL FORMULATIONS CONTAINING KETOPROFENE
DE102007013903A1 (en) drink

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: COSTATATION DE LA PERTE D UN DROIT CONFORMEMENT A LA REGLE 69(2) CBE (OEB FORMULAIRES 1205A DU 26.08.04 ET 28.09.04)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP